1. Academic Validation
  2. Inhibitors of NF-kappaB derived from thalidomide

Inhibitors of NF-kappaB derived from thalidomide

  • Bioorg Med Chem Lett. 2007 Nov 1;17(21):6031-5. doi: 10.1016/j.bmcl.2007.01.088.
Esperanza J Carcache de-Blanco 1 Bulbul Pandit Zhigen Hu Jiandong Shi Andrew Lewis Pui-Kai Li
Affiliations

Affiliation

  • 1 Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Abstract

A series of compounds originally derived from thalidomide were synthesized and evaluated. The most potent compounds in this series, 5HPP-33 and compound 20, inhibited NF-kappaB activation in HeLa cells. Preliminary study indicated that the mechanism of inhibition of NF-kappaB activation is through inhibition of its translocation from the cytoplasm to the nucleus.

Figures